Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania
<p>Abstract</p> <p>Background</p> <p>Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated <it>Plasmodium falciparum </it>malaria results in cure rates >95% with good tolerability.</p>...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/48 |